25451-15-4 | (3-carbamoyloxy-1,1,3,3-tetradeuterio-2-phenylpropyl) carbamate

Packsize	Purity	Availability	Price	Discounted Price
1mg	98%	in stock	$13.00	$9.00
5mg	98%	in stock	$45.00	$32.00
10mg	98%	in stock	$46.00	$32.00
25mg	98%	in stock	$76.00	$53.00
50mg	98%	in stock	$115.00	$80.00
100mg	98%	in stock	$175.00	$122.00
250mg	98%	in stock	$260.00	$182.00
1g	98%	in stock	$944.00	$661.00

Description

• Catalog Number: AI45899
• Chemical Name: (3-carbamoyloxy-1,1,3,3-tetradeuterio-2-phenylpropyl) carbamate
• CAS Number: 25451-15-4
• Molecular Formula: C11H14N2O4
• Molecular Weight: 238.2399
• MDL Number: MFCD00865296
• SMILES: NC(=O)OCC(c1ccccc1)COC(=O)N
• NSC Number: 759866

Computed Properties

• Complexity: 246
• Covalently-Bonded Unit Count: 1
• Heavy Atom Count: 17
• Hydrogen Bond Acceptor Count: 4
• Hydrogen Bond Donor Count: 2
• Rotatable Bond Count: 7
• XLogP3: 0.6

Literature

• Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis.

  Chemical research in toxicology 20150518

• A correlation between the in vitro drug toxicity of drugs to cell lines that express human P450s and their propensity to cause liver injury in humans.

  Toxicological sciences : an official journal of the Society of Toxicology 20140101

• Detection of 22 antiepileptic drugs by ultra-performance liquid chromatography coupled with tandem mass spectrometry applicable to routine therapeutic drug monitoring.

  Biomedical chromatography : BMC 20121201

• Insights into the novel hydrolytic mechanism of a diethyl 2-phenyl-2-(2-arylacetoxy)methyl malonate ester-based microsomal triglyceride transfer protein (MTP) inhibitor.

  Chemical research in toxicology 20121015

• The cost effectiveness of newer epilepsy treatments: a review of the literature on partial-onset seizures.

  PharmacoEconomics 20121001

• Shape-based reprofiling of FDA-approved drugs for the H₁ histamine receptor.

  Journal of medicinal chemistry 20120823

• Chemical properties of antiepileptic drugs (AEDs).

  Advanced drug delivery reviews 20120701

• Pharmacokinetic drug interactions between clobazam and drugs metabolized by cytochrome P450 isoenzymes.

  Pharmacotherapy 20120401

• Syntheses and evaluation of anticonvulsant activity of novel branched alkyl carbamates.

  Journal of medicinal chemistry 20120322

• Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice.

  Pharmacological research 20120301

• Prevalence of treated epilepsy in Korea based on national health insurance data.

  Journal of Korean medical science 20120301

• Weight-reducing side effects of the antiepileptic agents topiramate and zonisamide.

  Handbook of experimental pharmacology 20120101

• Clinical utility of adjunctive retigabine in partial onset seizures in adults.

  Therapeutics and clinical risk management 20120101

• Clinical decision support of therapeutic drug monitoring of phenytoin: measured versus adjusted phenytoin plasma concentrations.

  BMC medical informatics and decision making 20120101

• Recent progress in anticonvulsant drug research: strategies for anticonvulsant drug development and applications of antiepileptic drugs for non-epileptic central nervous system disorders.

  Current topics in medicinal chemistry 20120101

• The nervous system and metabolic dysregulation: emerging evidence converges on ketogenic diet therapy.

  Frontiers in neuroscience 20120101

• Analysis of selected anticonvulsants by high performance liquid chromatography-tandem mass spectrometry.

  Methods in molecular biology (Clifton, N.J.) 20120101

• New developments in the treatment of partial-onset epilepsy.

  Neuropsychiatric disease and treatment 20120101

• Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in a 24/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21/7 regimen.

  The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception 20111201

• Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).

  PLoS computational biology 20111201

• Nitric oxide, epileptic seizures, and action of antiepileptic drugs.

  CNS & neurological disorders drug targets 20111101

• Development of a highly sensitive cytotoxicity assay system for CYP3A4-mediated metabolic activation.

  Drug metabolism and disposition: the biological fate of chemicals 20110801

• Gabapentin: An update of its pharmacological properties and therapeutic use in epilepsy.

  Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences 20110801

• Antiepileptic drugs and the immune system.

  Epilepsia 20110501

• Rufinamide for the treatment of Lennox-Gastaut syndrome.

  Expert opinion on pharmacotherapy 20110401

• Management of seizures in Lennox-Gastaut syndrome.

  Paediatric drugs 20110401

• Depressogenic effects of medications: a review.

  Dialogues in clinical neuroscience 20110301

• From toxins targeting ligand gated ion channels to therapeutic molecules.

  Toxins 20110301

• Rhythmic delta activity represents a form of nonconvulsive status epilepticus in anti-NMDA receptor antibody encephalitis.

  Epilepsy & behavior : E&B 20110201

• Felbamate as an add-on therapy for refractory epilepsy.

  The Cochrane database of systematic reviews 20110119

• Low dose of bupropion significantly enhances the anticonvulsant activity of felbamate, lamotrigine and topiramate in mice.

  European journal of pharmacology 20110115

• Association of antiepileptic drugs with nontraumatic fractures: a population-based analysis.

  Archives of neurology 20110101

• Traditional and non-traditional treatments for autism spectrum disorder with seizures: an on-line survey.

  BMC pediatrics 20110101

• Management of provoked seizure.

  Annals of Indian Academy of Neurology 20110101

• Update on rufinamide in childhood epilepsy.

  Neuropsychiatric disease and treatment 20110101

• Treatment options for refractory and difficult to treat seizures: focus on vigabatrin.

  Therapeutics and clinical risk management 20110101

• Epilepsy, anti-epileptic drugs and bone health in children.

  Journal of pediatric neurosciences 20110101

• Prescribing medications in patients with decompensated liver cirrhosis.

  International journal of hepatology 20110101

• A comprehensive review of the literature on epilepsy in selected countries in emerging markets.

  Neuropsychiatric disease and treatment 20110101

• Comparison of the efficacy of carbamazepine, gabapentin and lamotrigine for neuropathic pain in rats.

  Indian journal of pharmacology 20110101

• Clobazam as an adjunctive therapy in treating seizures associated with Lennox-Gastaut syndrome.

  Neuropsychiatric disease and treatment 20110101

• Effect of Gentiana olivieri on experimental epilepsy models.

  Pharmacognosy magazine 20110101

• Rapid and sensitive LC-MS/MS method for determination of felbamate in mouse plasma and tissues and human plasma.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20101215

• A predictive ligand-based Bayesian model for human drug-induced liver injury.

  Drug metabolism and disposition: the biological fate of chemicals 20101201

• Use of antiepileptic drugs for hyperkinetic movement disorders.

  Current neuropharmacology 20101201

• 'Epileptic encephalopathy' of infancy and childhood: electro-clinical pictures and recent understandings.

  Current neuropharmacology 20101201

• Antiepileptic drug interactions - principles and clinical implications.

  Current neuropharmacology 20100901

• Periodic lateralized epileptiform discharges: Do they represent an ictal pattern requiring treatment?

  Epilepsy & behavior : E&B 20100701

• Update on antithrombotic therapy for stroke prevention in atrial fibrillation.

  Current treatment options in cardiovascular medicine 20100601

• Efficacy of felbamate in the treatment of intractable pediatric epilepsy.

  Pediatric neurology 20100601

• Effect of propranolol on functional connectivity in autism spectrum disorder--a pilot study.

  Brain imaging and behavior 20100601

• Diverse antiepileptic drugs increase the ratio of background synaptic inhibition to excitation and decrease neuronal excitability in neurones of the rat entorhinal cortex in vitro.

  Neuroscience 20100505

• Medical management of Lennox-Gastaut syndrome.

  CNS drugs 20100501

• [Antiepileptic drugs in North America].

  Brain and nerve = Shinkei kenkyu no shinpo 20100501

• Recent advances in adjunctive therapy for epilepsy: focus on sodium channel blockers as third-generation antiepileptic drugs.

  Drugs of today (Barcelona, Spain : 1998) 20100401

• A novel HPLC method for quantification of 10 antiepileptic drugs or metabolites in serum/plasma using a monolithic column.

  Therapeutic drug monitoring 20100201

• Simultaneous HPLC-UV analysis of rufinamide, zonisamide, lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in deproteinized plasma of patients with epilepsy.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20100201

• Behavioral and cognitive effects of anti-epileptic drugs.

  Discovery medicine 20100201

• Development of multi-electrode array screening for anticonvulsants in acute rat brain slices.

  Journal of neuroscience methods 20100115

• Drug interactions involving the new second- and third-generation antiepileptic drugs.

  Expert review of neurotherapeutics 20100101

• [Therapeutic drug monitoring of felbamate].

  Therapie 20100101

• Management of refractory complex partial seizures: current state of the art.

  Neuropsychiatric disease and treatment 20100101

• [Felbamate crystalluria].

  Annales de biologie clinique 20100101

• Treating Lennox-Gastaut syndrome in epileptic pediatric patients with third-generation rufinamide.

  Neuropsychiatric disease and treatment 20100101

• Bioassay-guided evaluation of antinociceptive effect of N-salicyloyltryptamine: a behavioral and electrophysiological approach.

  Journal of biomedicine & biotechnology 20100101

• Genetic variations in human glutathione transferase enzymes: significance for pharmacology and toxicology.

  Human genomics and proteomics : HGP 20100101

• Lennox-Gastaut syndrome: An overview.

  Journal of pediatric neurosciences 20100101

• Advances in epilepsy: new perspectives on new-onset epilepsy, comorbidities, and pharmacotherapy.

  F1000 medicine reports 20100101

• Selected pharmacokinetic issues of the use of antiepileptic drugs and parenteral nutrition in critically ill patients.

  Nutrition journal 20100101

• Weight-gain in psychiatric treatment: risks, implications, and strategies for prevention and management.

  Mens sana monographs 20100101

• Antiepileptic drugs and suicidality.

  Drug, healthcare and patient safety 20100101

• The interaction between clopidogrel and proton pump inhibitors (PPI): is there any clinical relevance?

  Clinical pharmacology : advances and applications 20100101

• Neuronal potassium channel openers in the management of epilepsy: role and potential of retigabine.

  Clinical pharmacology : advances and applications 20100101

• Medical treatment of pediatric urolithiasis.

  Pediatric nephrology (Berlin, Germany) 20091101

• Long-term use of felbamate: clinical outcomes and effect of age and concomitant antiepileptic drug use on its clearance.

  Epilepsia 20091101

• Metabolomics in drug intolerance.

  Current drug metabolism 20091101

• Iatrogenic QT Abnormalities and Fatal Arrhythmias: Mechanisms and Clinical Significance.

  Current cardiology reviews 20090801

• Treatment of Lennox-Gastaut syndrome.

  The Cochrane database of systematic reviews 20090708

• Antiepileptic drug monotherapy: the initial approach in epilepsy management.

  Current neuropharmacology 20090601

• Transitional polytherapy: tricks of the trade for monotherapy to monotherapy AED conversions.

  Current neuropharmacology 20090601

• Truly 'rational' polytherapy: maximizing efficacy and minimizing drug interactions, drug load, and adverse effects.

  Current neuropharmacology 20090601

• Minimizing AED adverse effects: improving quality of life in the interictal state in epilepsy care.

  Current neuropharmacology 20090601

• VEP indices of cortical lateral interactions in epilepsy treatment.

  Vision research 20090501

• Allopregnanolone (3alpha-hydroxy-5alpha-pregnan-20-one) derivatives with a polar chain in position 16alpha: synthesis and activity.

  Journal of medicinal chemistry 20090409

• [Empirical evidence for the use of anticonvulsants in personality disorders].

  Fortschritte der Neurologie-Psychiatrie 20090301

• Onset of action and seizure control in Lennox-Gaustaut syndrome: focus on rufinamide.

  Therapeutics and clinical risk management 20090101

• Current trends in the treatment of infantile spasms.

  Neuropsychiatric disease and treatment 20090101

• Neurological and neurobehavioral assessment of experimental subarachnoid hemorrhage.

  BMC neuroscience 20090101

• Symptomatic hypocalcemia in an epileptic child treated with valproic acid plus lamotrigine: a case report.

  Cases journal 20090101

• Update on the management of Lennox-Gastaut syndrome with a focus on rufinamide.

  Neuropsychiatric disease and treatment 20090101

• Drug-induced hematologic syndromes.

  Advances in hematology 20090101

• Felbamate in an adult population with severe refractory epilepsy.

  Irish medical journal 20090101

• Anticonvulsant Activity of Argyreia speciosa in Mice.

  Indian journal of pharmaceutical sciences 20090101

• ATP signalling in epilepsy.

  Purinergic signalling 20081201

• Mechanistic and pharmacologic aspects of status epilepticus and its treatment with new antiepileptic drugs.

  Epilepsia 20081201

• Treatment of Lennox-Gastaut syndrome: overview and recent findings.

  Neuropsychiatric disease and treatment 20081201

• Cross-sensitivity of skin rashes with antiepileptic drug use.

  Neurology 20081104

• New antiepileptic drugs in pediatric epilepsy.

  Brain & development 20081001

• Efficacy and safety of felbamate in children under 4 years of age: a retrospective chart review.

  European journal of neurology 20080901

• Can in vitro metabolism-dependent covalent binding data in liver microsomes distinguish hepatotoxic from nonhepatotoxic drugs? An analysis of 18 drugs with consideration of intrinsic clearance and daily dose.

  Chemical research in toxicology 20080901

• Cognitive effects of antiepileptic drugs.

  Journal of clinical neurology (Seoul, Korea) 20080901

• Approaches to treatment of type 2 diabetes.

  Diabetes care 20080801

• Greater response to placebo in children than in adults: a systematic review and meta-analysis in drug-resistant partial epilepsy.

  PLoS medicine 20080801

• Drug interactions between chemotherapeutic regimens and antiepileptics.

  Clinical therapeutics 20080801

• Tiagabine: efficacy and safety in partial seizures - current status.

  Neuropsychiatric disease and treatment 20080801

• Drug monitoring and toxicology: a simple procedure for the monitoring of felbamate by HPLC-UV detection.

  Journal of analytical toxicology 20080601

• Molecular determinants of the anticonvulsant felbamate binding site in the N-methyl-D-aspartate receptor.

  Journal of medicinal chemistry 20080327

• GABA(A) receptors in normal development and seizures: friends or foes?

  Current neuropharmacology 20080301

• Monotherapy for partial epilepsy: focus on levetiracetam.

  Neuropsychiatric disease and treatment 20080201

• Interactions of MRZ 2/576 with felbamate, lamotrigine, oxcarbazepine and topiramate in the mouse maximal electroshock-induced seizure model.

  Pharmacology 20080101

• Lennox gastaut syndrome, review of the literature and a case report.

  Head & face medicine 20080101

• Use of second-generation antiepileptic drugs in the pediatric population.

  Paediatric drugs 20080101

• Improvement in depressive symptoms with felbamate: a case report.

  Primary care companion to the Journal of clinical psychiatry 20080101

• Pharmacological management of epilepsy: recent advances and future prospects.

  Drugs 20080101

• The role of NMDA receptor subtypes in short-term plasticity in the rat entorhinal cortex.

  Neural plasticity 20080101

• Seizure control in patients with epilepsy: the physician vs. medication factors.

  BMC health services research 20080101

• [Endocrine effects of antiepileptic drugs].

  Przeglad lekarski 20080101

• [Effects of antiepileptic drugs on immune system].

  Przeglad lekarski 20080101

• Effects of new antiepileptic drugs and progabide on the mitogen-induced proliferative activity of mouse splenocytes.

  Pharmacological reports : PR 20080101

• Modifications of antiepileptic drugs for improved tolerability and efficacy.

  Perspectives in medicinal chemistry 20080101

• [Treatment of epilepsy with third-line antiepileptic drugs: felbamate, tiagabine, and sulthiame].

  Der Nervenarzt 20071201

• Felbamate but not phenytoin or gabapentin reduces glutamate release by blocking presynaptic NMDA receptors in the entorhinal cortex.

  Epilepsy research 20071201

• Topiramate in the treatment of partial and generalized epilepsy.

  Neuropsychiatric disease and treatment 20071201

• Development of membrane electrodes for selective determination of some antiepileptic drugs in pharmaceuticals, plasma and urine.

  Analytical and bioanalytical chemistry 20071101

• Treatment of drop attacks in Coffin-Lowry syndrome with the use of sodium oxybate.

  Pediatric neurology 20071101

• Assessment of antiepileptic drugs as substrates for canine P-glycoprotein.

  American journal of veterinary research 20071001

• Extracellular proton-modulated pore-blocking effect of the anticonvulsant felbamate on NMDA channels.

  Biophysical journal 20070915

• Characterization of the gating conformational changes in the felbamate binding site in NMDA channels.

  Biophysical journal 20070715

• Influence of levetiracetam on the anticonvulsant efficacy of conventional antiepileptic drugs against audiogenic seizures in DBA/2 mice.

  Epilepsy research 20070701

• Antiepileptic drugs and visual function.

  Pediatric neurology 20070601

• Comparison and predictors of rash associated with 15 antiepileptic drugs.

  Neurology 20070515

• A new look at the second-generation antiepileptic drugs: a decade of experience.

  The neurologist 20070501

• Levetiracetam and felbamate interact both pharmacodynamically and pharmacokinetically: an isobolographic analysis in the mouse maximal electroshock model.

  Epilepsia 20070401

• Evaluation of felbamate and other antiepileptic drug toxicity potential based on hepatic protein covalent binding and gene expression.

  Chemical research in toxicology 20070401

• NMDA receptor antagonist felbamate reduces behavioral deficits and blood-brain barrier permeability changes after experimental subarachnoid hemorrhage in the rat.

  Journal of neurotrauma 20070401

• Comparison of cognitive effects of lamotrigine and oxcarbazepine in epilepsy patients.

  Journal of clinical neurology (Seoul, Korea) 20070301

• [Psychotropic drug-induced change of weight: a review].

  Fortschritte der Neurologie-Psychiatrie 20070201

• Psychiatric and behavioral side effects of the newer antiepileptic drugs in adults with epilepsy.

  Epilepsy & behavior : E&B 20070201

• [Newer antiepileptic drugs].

  No to shinkei = Brain and nerve 20070201

• [Newer antiepileptic drugs].

  Brain and nerve = Shinkei kenkyu no shinpo 20070201

• Role of rufinamide in the management of Lennox-Gastaut syndrome (childhood epileptic encephalopathy).

  Neuropsychiatric disease and treatment 20070201

• Progress report on new antiepileptic drugs: a summary of the Eigth Eilat Conference (EILAT VIII).

  Epilepsy research 20070101

• Targets for antiepileptic drugs in the synapse.

  Medical science monitor : international medical journal of experimental and clinical research 20070101

• Discovery of antiepileptic drugs.

  Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 20070101

• Fluorofelbamate.

  Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 20070101

• Mechanisms of action of antiepileptic drugs.

  International review of neurobiology 20070101

• Negative effects of antiepileptic drugs on mood in patients with epilepsy.

  Drug safety 20070101

• [New antiepileptics in development].

  Pharmazie in unserer Zeit 20070101

• Enhanced glutamatergic transmission reduces the anticonvulsant potential of lamotrigine but not of felbamate against tonic-clonic seizures.

  Pharmacological reports : PR 20070101

• Weight issues for people with epilepsy--a review.

  Epilepsia 20070101

• Effects of some new antiepileptic drugs and progabide on glucocorticoid receptor-mediated gene transcription in LMCAT cells.

  Pharmacological reports : PR 20070101

• Optimizing therapy of seizures in patients with renal or hepatic dysfunction.

  Neurology 20061226

• Optimizing therapy of seizures in women who use oral contraceptives.

  Neurology 20061226

• Felbamate is a subunit selective modulator of recombinant gamma-aminobutyric acid type A receptors expressed in Xenopus oocytes.

  European journal of pharmacology 20061215

• Psychopharmacology of topiramate: from epilepsy to bipolar disorder.

  Neuropsychiatric disease and treatment 20061201

• Felbamate: consensus of current clinical experience.

  Epilepsy research 20061001

• Lamotrigine as a possible cause of QRS prolongation in a patient with known seizure disorder.

  CJEM 20060901

• Topiramate monotherapy in infantile spasm.

  Yonsei medical journal 20060831

• Enhancement of brain kynurenic acid production by anticonvulsants--novel mechanism of antiepileptic activity?

  European journal of pharmacology 20060717

• Diverse mechanisms of antiepileptic drugs in the development pipeline.

  Epilepsy research 20060601

• Microsphere-based protease assays and screening application for lethal factor and factor Xa.

  Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501

• Clinically relevant drug interactions with antiepileptic drugs.

  British journal of clinical pharmacology 20060301

• Interactions between antiepileptic and antipsychotic drugs.

  Drug safety 20060101

• Behavioral effects of ketamine and toxic interactions with psychostimulants.

  BMC neuroscience 20060101

• Clinical pharmacokinetics of new-generation antiepileptic drugs at the extremes of age.

  Clinical pharmacokinetics 20060101

• An epidemiological study on anemia among institutionalized people with intellectual and/or motor disability with special reference to its frequency, severity and predictors.

  BMC public health 20060101

• Pharmacokinetic variability of newer antiepileptic drugs: when is monitoring needed?

  Clinical pharmacokinetics 20060101

• Influence of NG-nitro-L-arginine on the anticonvulsant and acute adverse effects of some newer antiepileptic drugs in the maximal electroshock-induced seizures and chimney test in mice.

  Pharmacological reports : PR 20060101

• Simultaneous liquid chromatographic determination of lamotrigine, oxcarbazepine monohydroxy derivative and felbamate in plasma of patients with epilepsy.

  Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20051215

• Alteration of thyroid hormone homeostasis by antiepileptic drugs in humans: involvement of glucuronosyltransferase induction.

  European journal of clinical pharmacology 20051201

• Household disposal of pharmaceuticals as a pathway for aquatic contamination in the United kingdom.

  Environmental health perspectives 20051201

• Stability and comparative metabolism of selected felbamate metabolites and postulated fluorofelbamate metabolites by postmitochondrial suspensions.

  Chemical research in toxicology 20051201

• Pharmacokinetic variability of new antiepileptic drugs at different ages.

  Therapeutic drug monitoring 20051201

• The pharmacokinetics and interactions of new antiepileptic drugs: an overview.

  Therapeutic drug monitoring 20051201

• Induction of endogenous pathways by antiepileptics and clinical implications.

  Fundamental & clinical pharmacology 20051001

• Effect of antiepileptic drug comedication on lamotrigine clearance.

  Archives of neurology 20050901

• Effects of anticonvulsants on soman-induced epileptiform activity in the guinea-pig in vitro hippocampus.

  European journal of pharmacology 20050822

• Prediction of genotoxicity of chemical compounds by statistical learning methods.

  Chemical research in toxicology 20050601

• NMDA/NR2B selective antagonists in the treatment of ischemic brain injury.

  Current drug targets. CNS and neurological disorders 20050401

• Interaction between lamotrigine and felbamate in the maximal electroshock-induced seizures in mice: an isobolographic analysis.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20050301

• Felbamate reduces hormone release and locomotor hypoactivity induced by repeated stress of social defeat in mice.

  European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20050301

• Pharmacodynamic and pharmacokinetic interaction studies of loreclezole with felbamate, lamotrigine, topiramate, and oxcarbazepine in the mouse maximal electroshock seizure model.

  Epilepsia 20050301

• Analysis of antiepileptic drugs in biological fluids by means of electrokinetic chromatography.

  Electrophoresis 20050201

• Mechanisms of action of antiepileptic drugs.

  Current topics in medicinal chemistry 20050101

• Bupropion-induced convulsions: preclinical evaluation of antiepileptic drugs.

  Epilepsy research 20050101

• Acute felbamate overdose with crystalluria.

  Clinical toxicology (Philadelphia, Pa.) 20050101

• Ion channels and epilepsy.

  Current pharmaceutical design 20050101

• [Pharmacokinetic mechanisms underlying resistance in psychopharmacological treatment. The role of P-glycoprotein].

  Vertex (Buenos Aires, Argentina) 20050101

• [The effect of MDR1 gene polymorphism in the pathogenesis and the treatment of drug-resistant epilepsy].

  Neurologia i neurochirurgia polska 20050101

• Management of Landau-Kleffner syndrome.

  Paediatric drugs 20050101

• Profile of anticonvulsant activity and neuroprotective effects of novel and potential antiepileptic drugs--an update.

  Pharmacological reports : PR 20050101

• [Therapies for Lennox-Gastaut syndrome].

  Srpski arhiv za celokupno lekarstvo 20050101

• [Current pharmacotherapy of epilepsy in adults].

  Bulletin de la Societe des sciences medicales du Grand-Duche de Luxembourg 20050101

• Investigating the role of 2-phenylpropenal in felbamate-induced idiosyncratic drug reactions.

  Chemical research in toxicology 20041201

• Efficacy and tolerability of the new antiepileptic drugs: comparison of two recent guidelines.

  The Lancet. Neurology 20041001

• Isobolographic and subthreshold analysis of interactions among felbamate and four conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice.

  Epilepsia 20041001

• Side effects of antiepileptics--a review.

  Pain practice : the official journal of World Institute of Pain 20040901

• Preclinical profile of combinations of some second-generation antiepileptic drugs: an isobolographic analysis.

  Epilepsia 20040801

• Pharmacodynamic interaction studies with topiramate in the pentylenetetrazol and maximal electroshock seizure models.

  Seizure 20040701

• [Treatment protocol for long-term anti-epilepsy drugs in adults with refractory partial epilepsy].

  Revue neurologique 20040601

• Regulation of cellular plasticity and resilience by mood stabilizers: the role of AMPA receptor trafficking.

  Dialogues in clinical neuroscience 20040601

• Effect of felbamate and its combinations with conventional antiepileptics in amygdala-kindled rats.

  Pharmacology, biochemistry, and behavior 20040501

• Adverse effects of new antiepileptic drugs.

  Drugs of today (Barcelona, Spain : 1998) 20040401

• [Drug interactions with antiepileptic agents].

  Wiener klinische Wochenschrift 20040227

• A new linker for glucuronylated anticancer prodrugs.

  Bioorganic & medicinal chemistry 20040215

• The new antiepileptic drugs: scientific review.

  JAMA 20040204

• Use-dependent inhibition of the N-methyl-D-aspartate currents by felbamate: a gating modifier with selective binding to the desensitized channels.

  Molecular pharmacology 20040201

• Influence of carbenoxolone on the anticonvulsant efficacy of conventional antiepileptic drugs against audiogenic seizures in DBA/2 mice.

  European journal of pharmacology 20040119

• Behavioural effects of the newer antiepileptic drugs: an update.

  Expert opinion on drug safety 20040101

• Treatment of partial seizures in childhood : an overview.

  CNS drugs 20040101

• Effects of seven clinically important antiepileptic drugs on inhibitory glycine receptor currents in hippocampal neurons.

  Epilepsy research 20040101

• New antiepileptic agents.

  Pediatric dentistry 20040101

• Is there any future for felbamate treatment?

  Polish journal of pharmacology 20040101

• Pharmacologic treatment of the catastrophic epilepsies.

  Epilepsia 20040101

• Significance of MDR1 and multiple drug resistance in refractory human epileptic brain.

  BMC medicine 20040101

• Influence of felbamate on selected central effects of ethanol in experimental animals.

  Acta poloniae pharmaceutica 20040101

• Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII).

  Epilepsy research 20040101

• Therapeutic drug monitoring of old and newer anti-epileptic drugs.

  Clinical chemistry and laboratory medicine 20040101

• Effect of lamotrigine combined with felbamate on the horizontal (ambulatory) activity in mice.

  Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 20040101

• [Anticonvulsive activity of antiepileptic drugs and quantum-chemical modelling of their interaction with GABA(A) receptor].

  Ukrains'kyi biokhimichnyi zhurnal (1999 ) 20040101

• Treatment of refractory primary generalized epilepsy.

  Reviews in neurological diseases 20040101

• Brain access and anticonvulsant efficacy of carbamazepine, lamotrigine, and felbamate in ABCC2/MRP2-deficient TR- rats.

  Epilepsia 20031201

• Epilepsy and adolescents.

  Panminerva medica 20031201

• Infantile spasms.

  Expert opinion on pharmacotherapy 20031101

• Effects of antiepileptic drugs on refractory seizures in the intact immature corticohippocampal formation in vitro.

  Epilepsia 20031101

• Relationship between extent of inhibition and inhibitor dose: literature evaluation based on the metabolism and transport drug interaction database.

  Current drug metabolism 20031001

• Is the interaction between felbamate and valproate against seizures induced by 4-aminopyridine and pentylenetetrazole in mice beneficial?

  Pharmacological research 20030801

• Synthesis and anticonvulsant activity of novel bicyclic acidic amino acids.

  Journal of medicinal chemistry 20030703

• In vivo CYP3A4 heteroactivation is a possible mechanism for the drug interaction between felbamate and carbamazepine.

  The Journal of pharmacology and experimental therapeutics 20030601

• Therapeutic drug monitoring of the newer antiepileptic drugs.

  Therapeutic drug monitoring 20030601

• Interactions of tiagabine with some antiepileptics in the maximal electroshock in mice.

  Pharmacology, biochemistry, and behavior 20030501

• The ideal pharmacokinetic properties of an antiepileptic drug: how close does levetiracetam come?

  Epileptic disorders : international epilepsy journal with videotape 20030501

• Synergistic interaction between felbamate and lamotrigine against seizures induced by 4-aminopyridine and pentylenetetrazole in mice.

  European journal of pharmacology 20030328

• [New epileptic treatments. Current modalities and their utilization].

  Presse medicale (Paris, France : 1983) 20030308

• Neuroprotective effects of anticonvulsants in rat hippocampal slice cultures exposed to oxygen/glucose deprivation.

  Neuroscience letters 20030102

• Drug treatment of epilepsy in elderly people: focus on valproic Acid.

  Drugs & aging 20030101

• Interlaboratory variability in the quantification of new generation antiepileptic drugs based on external quality assessment data.

  Epilepsia 20030101

• Pharmacogenetics--the horizon.

  Reviews in gastroenterological disorders 20030101

• Selection criteria for the clinical use of the newer antiepileptic drugs.

  CNS drugs 20030101

• Clinical care of pregnant women with epilepsy: neural tube defects and folic acid supplementation.

  Epilepsia 20030101

• Treatment of Lennox-Gastaut syndrome.

  The Cochrane database of systematic reviews 20030101

• Effect of antiepileptic drugs on bodyweight: overview and clinical implications for the treatment of epilepsy.

  CNS drugs 20030101

• Influence of felbamate on the antinociceptive action of morphine, metamizol and indomethacin in mice.

  Acta poloniae pharmaceutica 20030101

• Influence of some convulsant agents on the protective activity of a novel antiepileptic drug, felbamate, against maximal electroshock in mice.

  Polish journal of pharmacology 20030101

• Rapid and simple high-performance liquid chromatographic determination of felbamate in serum.

  Acta poloniae pharmaceutica 20030101

• Antiepileptic drug therapy for adults: when to initiate and how to choose.

  Mayo Clinic proceedings 20021201

• Mechanisms of idiosyncratic drug reactions: the case of felbamate.

  Chemico-biological interactions 20021110

• Reactivity of atropaldehyde, a felbamate metabolite in human liver tissue in vitro.

  Chemico-biological interactions 20021110

• Polytherapy in epilepsy: the experimental evidence.

  Epilepsy research 20021101

• New antiepileptic drug therapies.

  Neurologic clinics 20021101

• Anticonvulsant and antiepileptogenic effects of fluorofelbamate in experimental status epilepticus.

  Seizure 20021001

• Vagus nerve stimulation in a case of epilepsy with CSWSS: respiratory side effects during sleep.

  Epilepsia 20021001

• New antiepileptic drugs in childhood.

  Panminerva medica 20020901

• [Monitoring serum levels of new antiepileptics].

  Revista de neurologia 20020901

• P-Glycoprotein-mediated efflux of phenobarbital, lamotrigine, and felbamate at the blood-brain barrier: evidence from microdialysis experiments in rats.

  Neuroscience letters 20020726

• Interaction between human serum albumin and the felbamate metabolites 4-Hydroxy-5-phenyl-[1,3]oxazinan-2-one and 2-phenylpropenal.

  Chemical research in toxicology 20020601

• [New antiepileptic drugs: new therapeutic options].

  Revue neurologique 20020501

• Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.

  The Journal of biological chemistry 20020419

• Some common issues in the use of antiepileptic drugs.

  Seminars in neurology 20020301

• New antiepileptic drugs.

  The neurologist 20020301

• Marketed new antiepileptic drugs: are they better than old-generation agents?

  Therapeutic drug monitoring 20020201

• New antiepileptic drugs: review on drug interactions.

  Therapeutic drug monitoring 20020201

• Mechanisms underlying the nociception and paw oedema caused by injection of glutamate into the mouse paw.

  Brain research 20020111

• Felbamate-induced apoptosis of hematopoietic cells is mediated by redox-sensitive and redox-independent pathways.

  Epilepsy research 20020101

• Anticonvulsants: aspects of their mechanisms of action.

  European journal of pain (London, England) 20020101

• Pediatric partial and generalized seizures.

  Journal of child neurology 20020101

• Interactions between antiepileptic drugs and hormonal contraception.

  CNS drugs 20020101

• Medical treatment of patients with infantile spasms.

  Clinical neuropharmacology 20020101

• Antiepileptic drugs and agents that inhibit voltage-gated sodium channels prevent NMDA antagonist neurotoxicity.

  Molecular psychiatry 20020101

• Anticonvulsant drug hypersensitivity.

  Journal of investigational allergology & clinical immunology 20020101

• Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy.

  Epilepsy research 20011201

• Clinical pharmacology and therapeutic use of the new antiepileptic drugs.

  Fundamental & clinical pharmacology 20011201

• The long-term use of felbamate in children with severe refractory epilepsy.

  Epilepsy research 20011101

• The NMDA receptor complex: a promising target for novel antiepileptic strategies.

  Current medicinal chemistry 20010901

• Newer antiepileptic drugs: advantages and disadvantages.

  Brain & development 20010801

• The chemistry, toxicology, and identification in rat and human urine of 4-hydroxy-5-phenyl-1,3-oxazaperhydroin-2-one: a reactive metabolite in felbamate bioactivation.

  Chemical research in toxicology 20010801

• Treatment of partial seizures and seizure-like activity with felbamate in six dogs.

  The Journal of small animal practice 20010801

• Advances in the treatment of epilepsy.

  American family physician 20010701

• The role of new antiepileptic drugs.

  The American journal of managed care 20010701

• Role of glutathione S-transferases A1-1, M1-1, and P1-1 in the detoxification of 2-phenylpropenal, a reactive felbamate metabolite.

  Chemical research in toxicology 20010501

• Felbamate urolithiasis.

  Epilepsia 20010501

• Monotherapy trials: presurgical studies.

  Epilepsy research 20010501

• Second generation anticonvulsant medications: their use in children.

  The Journal of school nursing : the official publication of the National Association of School Nurses 20010401

• Influence of retigabine on the anticonvulsant activity of some antiepileptic drugs against audiogenic seizures in DBA/2 mice.

  Naunyn-Schmiedeberg's archives of pharmacology 20010301

• [Antiepileptic drugs and neuropathic pain].

  Revista de neurologia 20010201

• Progress report on new antiepileptic drugs: a summary of the Fifth Eilat Conference (EILAT V).

  Epilepsy research 20010101

• [Controversies about the new anti-epileptic drugs].

  Revista de neurologia 20010101

• Pharmacologic management of epilepsy in the elderly.

  Journal of the American Pharmaceutical Association (Washington,D.C. : 1996) 20010101

• Felbamate, gabapentin and topiramate as adjuvant antiepileptic drugs in experimental models of epilepsy.

  Polish journal of pharmacology 20010101

• [New antiepileptic drugs in childhood epilepsies: indications and limits].

  Epileptic disorders : international epilepsy journal with videotape 20010101

• [West syndrome--new therapeutic approach].

  Srpski arhiv za celokupno lekarstvo 20010101

• A self-complementary, self-assembling microsphere system: application for intravenous delivery of the antiepileptic and neuroprotectant compound felbamate.

  Journal of pharmaceutical sciences 20000701

• Felbamate block of recombinant N-methyl-D-aspartate receptors: selectivity for the NR2B subunit.

  Epilepsy research 20000301

• Felbamate in experimental model of status epilepticus.

  Epilepsia 20000201

• Preclinical evaluation of newly approved and potential antiepileptic drugs against cocaine-induced seizures.

  The Journal of pharmacology and experimental therapeutics 19990901

• Subtype-selective antagonism of N-methyl-D-aspartate receptors by felbamate: insights into the mechanism of action.

  The Journal of pharmacology and experimental therapeutics 19990501

• Effects of anti-epileptic drugs on glutamine synthetase activity in mouse brain.

  British journal of pharmacology 19990401

• Acute, subchronic, and chronic toxicity studies with felbamate, 2-phenyl-1,3-propanediol dicarbamate.

  Toxicological sciences : an official journal of the Society of Toxicology 19981001

• Excitatory amino acid antagonists alleviate convulsive and toxic properties of lindane in mice.

  Pharmacology & toxicology 19980301

• Effects of new anticonvulsant medications on porphyrin synthesis in cultured liver cells: potential implications for patients with acute porphyria.

  Neurology 19970701

• Antagonism of convulsions but failure to enhance GABA(A) receptor function by felbamate in mice tolerant to diazepam.

  Neurochemical research 19970601

• Lamotrigine pharmacokinetics in patients receiving felbamate.

  Epilepsy research 19970401

• Felbamate decreases synaptic transmission in the CA1 region of rat hippocampal slices.

  The Journal of pharmacology and experimental therapeutics 19961201

• Anticonvulsant activity of 5,7DCKA, NBQX, and felbamate against some chemoconvulsants in DBA/2 mice.

  Pharmacology, biochemistry, and behavior 19961001

• Felbamate protects CA1 neurons from apoptosis in a gerbil model of global ischemia.

  Stroke 19960701

• Effects of felbamate on muscarinic and metabotropic-glutamate agonist-mediated responses and magnesium-free or 4-aminopyridine-induced epileptiform activity in guinea pig olfactory cortex neurons in vitro.

  The Journal of pharmacology and experimental therapeutics 19960601

• The effect of age on the apparent clearance of felbamate: a retrospective analysis using nonlinear mixed-effects modeling.

  Therapeutic drug monitoring 19960201

• Neuropsychiatric side effects related to treatment with felbamate.

  The Journal of neuropsychiatry and clinical neurosciences 19960101

• Excitoprotective effect of felbamate in cultured cortical neurons.

  Brain research 19951224

• The severity of naloxone-precipitated opiate withdrawal is attenuated by felbamate, a possible glycine antagonist.

  Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 19951201

• Felbamate modulates the strychnine-insensitive glycine receptor.

  Epilepsy research 19950101

• Felbamate displays in vitro antiepileptic effects as a broad spectrum excitatory amino acid receptor antagonist.

  European journal of pharmacology 19941227

• Felbamate antagonizes isoniazid- and FG 7142-induced reduction of GABAA receptor function in mouse brain.

  European journal of pharmacology 19941124

• Felbamate, an anti-convulsive drug, has anti-parkinsonian potential in rats.

  Neuroscience letters 19940926

• Excitatory amino acid neurotransmission through both NMDA and non-NMDA receptors is involved in the anticonvulsant activity of felbamate in DBA/2 mice.

  European journal of pharmacology 19940901

• Felbamate, a novel antiepileptic agent, does not affect cognition in rodents.

  Behavioural pharmacology 19940601

• Comparative effects of felbamate and other compounds on N-methyl-D-aspartic acid-induced convulsions and lethality in mice.

  Pharmacological research 19940101

• Posthypoxic treatment with felbamate is neuroprotective in a rat model of hypoxia-ischemia.

  Neurology 19931101

• Effects of felbamate and other anticonvulsant drugs in two models of status epilepticus in the rat.

  Research communications in chemical pathology and pharmacology 19930301

• Effects of anticonvulsant drugs on 4-aminopyridine-induced seizures in mice.

  Epilepsy research 19920301

• Felbamate for partial seizures: results of a controlled clinical trial.

  Neurology 19911101

• Interaction of felbamate and diazepam against maximal electroshock seizures and chemoconvulsants in mice.

  Pharmacology, biochemistry, and behavior 19910901

• The effect of chronic felbamate administration on anticonvulsant activity and hepatic drug-metabolizing enzymes in mice and rats.

  Epilepsia 19870101

• Comparative anticonvulsant activity and neurotoxicity of felbamate and four prototype antiepileptic drugs in mice and rats.

  Epilepsia 19860101